Tumours of the Urinary System 2: Urothelial and Renal Cancers Flashcards
what are sites of urothelial tumours?
Malignant tumours of the lining transitional cell epithelium (urothelium) can occur at any point
from renal calyces
to the tip of the urethra.
Most common site - bladder - 90%
“Bladder Cancer”
what is the most common tumour type for bladder cancer?
transitional cell carcinoma (i.e. 90% in UK)
what are the risk factors for bladder cancer?
smoking (accounts for 40% of cases)
aromatic amines
non-hereditary genetic abnormalities (e.g. TSG incl. p53 and Rb)
what are risk factors for squamous cell carcinoma bladder cancer?
Schistosomiasis (S. haematobium only)
chronic cystitis (e.g. recurrent UTI, long term catheter, bladder stone)
cyclophosphamide therapy
pelvic radiotherapy
Adenocarcinoma
-Urachal
what is the most frequent presenting symptom of bladder cancer?
painless visible haematuria
what are occasional symptoms of bladder cancer?
Occasionally
symptoms due to invasive or metastatic disease
recurrent UTI
storage bladder symptoms
dysuria, frequency, nocturia, urgency +/- urge incontinence
bladder pain
if present, suspect CIS
how may haematuria present?
Frank - reported by patient
Microscopic - detected by doctor
what should be done urgently in investigation of haematuria?
Upper tract imaging
CT Urogram (IVU)
ultrasound scan
Urine Cytology
Limited use in Dipstick haematuria
BP and U&E’s
what should be done in investigation of haematuria?
Urine culture
majority of painful haematuria = UTI
Cystourethroscopy
commonest neoplastic cause is TCC bladder
what investigations should be done for frank haematuria?
> 50 yrs - Risk of malignancy - 25-35%
Flexible cystourethroscopy within 2 weeks
IVU & USS
CT Urogram & USS
Urine Cytology may also be useful (but not very sensitive nor specific)
what investigation should be done for microscopic haematuria?
> 50 yrs - Risk of malignancy - 5-10%
Flexible cystourethroscopy within 4-6 weeks
USS
how are urothelial tumours diagnosed?
IVU alone will miss a proportion of renal cell tumours (especially if <3cm)
USS alone will miss a proportion of urothelial tumours of the upper tracts
cystoscopy and endoscopic resection (TURBT)
EUA to assess bladder mass/thickening before and after TURBT
how are urothelial tumours in the bladder staged?
cross-sectional imaging (CT, MRI)
Bone scan if symptomatic
CTU for upper tract TCC (2-7% risk over 10 years; higher risk if high grade, stage or multifocal bladder tumours)
what is treatment available for urothellial tumours of the bladder?
endoscopic or radical
how are bladder tumours classified?
Grade of tumour
Stage of tumour
- TNM classification
- T-stage :
- non-muscle invasive (or ‘superficial’)
- muscle invasive
Combined to describe TCC e.g. G1pTa
what does appropriate treatment of bladder cancer depend?
Site
Clinical stage
Histological grade of tumour
Patient age and co-morbidities
what is treatment for Low grade non-muscle invasive (i.e. Ta or T1)?
endoscopic resection followed by single instillation of intravesical chemotherapy (mitomycin C) within 24 hours
prolonged endoscopic follow up for moderate grade tumours
consider prolonged course of intravesical chemotherapy (6 weeks months) for repeated recurrences
what is treatment for High grade non-muscle invasive or CIS?
very aggressive – 50-80% risk of progression to muscle invasive stage
endoscopic resection alone not sufficient
CIS consider intravesical BCG therapy (maintenance course, weekly for 3 weeks repeated 6 monthly over 3 years)
patients refractory to BCG – need radical surgery
what is treatment for muscle invasive bladder (T2 - T3)?
neoadjuvant chemotherapy for local (i.e. downstaging) and systemic control; followed by either :
radical radiotherapy and/or;
radical cystoprostatectomy (men) or anterior pelvic exenteration with urethrectomy (women); with extended lymphadenectomy
radical surgery combined with incontinent urinary diversion (i.e. ileal conduit), continent diversion (e.g. bowel pouch with catheterisable stoma) or orthotopic bladder substitution
what is prognosis of bladder cancer dependent on?
stage
grade
size
multifocality
presence of concurrent CIS
recurrence at 3 months
what is the five year survival of non-invasive, low grade bladder TCC?
90% 5-year survival
what is the five year survival of invasive, high grade bladder TCC?
50%
Upper tract TCC (or upper tract urothelial cancer – UTUC) main symptoms?
Frank haematuria
Unilateral ureteric obstruction
Flank or loin pain
Symptoms of nodal or metastatic disease
Bone pain
Hypercalcaemia
Lung
Brain
what diagnostic investigations are done for UTUC?
CT-IVU or IVU
Urine cytology
Ureteroscopy and biopsy